
Blinatumomab: Uses, Dosage, Side Effects, Warnings - Drugs.com
2024年7月8日 · Blinatumomab (Blincyto) is an injectable immunotherapy treatment that may be used to treat B-cell precursor acute lymphoblastic leukemia (ALL) in adults and children aged 1 month and older. It is a biologic treatment that is usually given after other cancer treatments have been tried without success.
Blinatumomab - Wikipedia
Blinatumomab, sold under the brand name Blincyto, is a biopharmaceutical medication used for the treatment of Philadelphia chromosome -negative relapsed or refractory acute lymphoblastic leukemia. [9] .
B-Cell Precursor ALL Treatment | BLINCYTO® (blinatumomab)
WHAT IS BLINCYTO ® (blinatumomab)? B-cell precursor acute lymphoblastic leukemia (ALL) in remission when only a small number of cancer cells remain in the body (minimal residual …
Blincyto (blinatumomab) - Uses, Side Effects, and More - WebMD
2024年10月23日 · Blincyto (blinatumomab) is commonly used to treat certain acute lymphoblastic leukemia (ALL) cancers. Blincyto may also be used for other conditions as determined by your healthcare provider. How...
Blinatumomab versus Chemotherapy for Advanced Acute …
2017年3月2日 · In this multi-institutional phase 3 trial, we randomly assigned adults with heavily pretreated B-cell precursor ALL, in a 2:1 ratio, to receive either blinatumomab or standard-of-care...
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia …
2024年7月24日 · Many older adults with B-cell precursor acute lymphoblastic leukemia (BCP-ALL) have a relapse despite having a measurable residual disease (MRD)–negative complete remission with combination...
Blinatumomab - NCI - National Cancer Institute
Blinatumomab is a type of immunotherapy drug called a bispecific T-cell engager (BiTE). FDA label information for this drug is available at DailyMed. Blinatumomab is approved to treat: B-cell acute lymphoblastic leukemia that is CD19 positive in …
Blinatumomab Extends Life for People with ALL in Remission
2023年1月25日 · Blinatumomab is a type of immunotherapy called a bispecific T-cell engager (BiTE). It simultaneously attaches to T cells and cancer cells, enabling T cells to easily find and destroy the cancer cell by bringing them closer together.
Blinatumomab Effective for Children with Relapsed Leukemia
2021年4月1日 · Blinatumomab, a type of immunotherapy, binds to certain molecules on leukemia cells and T cells, bringing the T cells close enough to the leukemia cells to kill them.
Blinatumomab - Memorial Sloan Kettering Cancer Center
2022年12月12日 · What is this drug used for? It is used to treat a type of leukemia. What do I need to tell my doctor BEFORE I take this drug? If you are allergic to this drug; any part of this drug; or any other drugs, foods, or substances. Tell your doctor about the allergy and what signs you had. If you are breast-feeding.